Treatment of Croup in Infants
Administer a single dose of oral dexamethasone 0.6 mg/kg (maximum 10 mg) for all infants with croup, regardless of severity, and add nebulized epinephrine for moderate-to-severe cases. 1, 2, 3
Corticosteroid Therapy (First-Line for All Cases)
Dexamethasone is the preferred corticosteroid due to its long half-life and ease of administration. The evidence strongly supports:
- Dose: 0.6 mg/kg orally (maximum 10 mg) as a single dose 1, 2, 3
- Lower doses (0.15 mg/kg) may be equally effective but evidence is less robust 2, 4
- Route: Oral is preferred; intramuscular or intravenous can be used if oral route unavailable 2, 3
- Timing of effect: Symptom improvement begins within 2-6 hours 2, 5
The Cochrane review demonstrates that glucocorticoids reduce croup scores at 6 hours (SMD -0.76), 12 hours (SMD -1.03), decrease return visits by 50% (RR 0.5), and shorten hospital stays by approximately 12 hours 2, 5. This evidence is consistent across multiple high-quality studies.
Alternative: Prednisolone shows similar efficacy to dexamethasone but requires multiple doses, making it less practical 2.
Nebulized Epinephrine (For Moderate-to-Severe Croup)
Add nebulized epinephrine when the infant has:
- Stridor at rest
- Moderate-to-severe respiratory distress
- Chest wall retractions
- Racemic epinephrine: 0.5 mL/kg of 2.25% solution (maximum 0.5 mL) diluted in 2 mL normal saline
- L-epinephrine (if racemic unavailable): 0.5 mL/kg of 1:1000 solution (maximum 5 mL) via nebulizer
Critical caveat: Epinephrine's effect is short-lived (1-2 hours) 6. Observe the infant for at least 2-4 hours after administration before considering discharge, as symptoms may recur when the medication wears off 6, 7. The British Thoracic Society explicitly warns against using nebulized epinephrine in children who will be discharged shortly or on an outpatient basis 6.
Observation and Disposition Guidelines
For infants receiving 2 doses of racemic epinephrine 7:
- Monitor for 2 hours after the second dose
- Assess need for third dose before admission decision
- Only 16.9% of children receiving 2 RE doses actually require additional treatment 7
Admission criteria:
- Need for 3 or more doses of epinephrine
- Persistent stridor at rest after treatment
- Significant respiratory distress despite therapy
- Inability to maintain adequate hydration
- Concerns about caregiver ability to monitor at home
What NOT to Do
Avoid these interventions as they lack evidence or cause harm:
- Humidified air/mist therapy: No demonstrable benefit in acute settings 4
- Antibiotics: Croup is viral; antibiotics are not indicated
- Cough suppressants or OTC medications: Ineffective and potentially harmful in young children 8
- Routine radiography: Reserve for suspected alternative diagnoses (epiglottitis, foreign body, bacterial tracheitis) 3
- Nebulized budesonide alone: May reduce symptoms in first 2 hours but no data on longer-term outcomes 6
Practical Algorithm
- Diagnose croup: Barking cough + inspiratory stridor + hoarseness
- Give dexamethasone 0.6 mg/kg PO immediately (all severity levels)
- Assess severity:
- Mild (no stridor at rest): Observe 2-4 hours, discharge if stable
- Moderate-to-severe (stridor at rest, retractions): Add nebulized epinephrine
- After epinephrine: Observe minimum 2 hours (preferably 4 hours)
- Reassess: If improved and stable, discharge with return precautions
- If requiring ≥3 epinephrine doses: Admit for continued monitoring
Key Pitfalls to Avoid
- Discharging too soon after epinephrine: The rebound effect can occur 1-2 hours later when medication wears off
- Withholding steroids in mild cases: Even mild croup benefits from dexamethasone, reducing return visits and progression
- Using higher steroid doses unnecessarily: 0.6 mg/kg is sufficient; higher doses don't improve outcomes 2
- Confusing croup with epiglottitis: Epiglottitis presents with drooling, toxic appearance, and absence of barking cough—this requires immediate airway management, not nebulized treatments